These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31682840)

  • 1. Enrichment of Polyfunctional IL-17-Producing T Cells in Paradoxical Psoriasis Skin Lesions.
    Moran B; Gallagher C; Tobin AM; Fletcher JM
    J Invest Dermatol; 2020 May; 140(5):1094-1097. PubMed ID: 31682840
    [No Abstract]   [Full Text] [Related]  

  • 2. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-23 promotes CD103-negative Th17 in psoriatic non-lesional skin.
    Matsumura Y; Watanabe R; Vo S; Koguchi-Yoshioka H; Furuta J; Inoue S; Ishitsuka Y; Nakamura Y; Okiyama N; Fujisawa Y; Fujimoto M
    J Dermatol Sci; 2021 Jan; 101(1):72-74. PubMed ID: 33143963
    [No Abstract]   [Full Text] [Related]  

  • 4. Unopposed IL-36 Activity Promotes Clonal CD4
    Arakawa A; Vollmer S; Besgen P; Galinski A; Summer B; Kawakami Y; Wollenberg A; Dornmair K; Spannagl M; Ruzicka T; Thomas P; Prinz JC
    J Invest Dermatol; 2018 Jun; 138(6):1338-1347. PubMed ID: 29288651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In the Red: Deficits in Immune Regulation Underlie Psoriasis Severity.
    Johnston A
    J Invest Dermatol; 2016 Nov; 136(11):2124-2126. PubMed ID: 27772545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistent skin lesions of vitiligo and psoriasis vulgaris. Immunohistochemical analyses for IL-17A-producing cells and regulatory T cells.
    Ono S; Tanizaki H; Otsuka A; Endo Y; Koyanagi I; Kataoka TR; Miyachi Y; Kabashima K
    Acta Derm Venereol; 2014 May; 94(3):329-30. PubMed ID: 24129673
    [No Abstract]   [Full Text] [Related]  

  • 8. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
    Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
    J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptococcus pyogenes-induced cutaneous lymphocyte antigen-positive T cell-dependent epidermal cell activation triggers TH17 responses in patients with guttate psoriasis.
    Ruiz-Romeu E; Ferran M; Sagristà M; Gómez J; Giménez-Arnau A; Herszenyi K; Hóllo P; Celada A; Pujol R; Santamaria-Babí LF
    J Allergy Clin Immunol; 2016 Aug; 138(2):491-499.e6. PubMed ID: 27056267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgaris.
    Niu X; Cao W; Ma H; Feng J; Li X; Zhang X
    J Dermatol; 2012 Nov; 39(11):916-21. PubMed ID: 22913391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
    Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
    Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
    Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
    Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
    Lovato P; Norsgaard H; Tokura Y; Røpke MA
    J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis and other Th17-mediated skin diseases.
    Tokura Y; Mori T; Hino R
    J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of IL-17-producing CD4/CD8 double negative αβ T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model.
    Ueyama A; Imura C; Fusamae Y; Tsujii K; Furue Y; Aoki M; Suzuki M; Okuda T; Oshima I; Yasui K; Shichijo M; Yamamoto M
    J Dermatol Sci; 2017 Jan; 85(1):27-35. PubMed ID: 27810232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of interleukin (IL)-17A+ T lymphocytes and IL-17A expression in treatment-resistant psoriatic plaques despite ustekinumab therapy.
    Jack C; Mashiko S; Arbour N; Bissonnette R; Sarfati M
    Br J Dermatol; 2017 Jul; 177(1):267-270. PubMed ID: 27599204
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis.
    Sofen H; Smith S; Matheson RT; Leonardi CL; Calderon C; Brodmerkel C; Li K; Campbell K; Marciniak SJ; Wasfi Y; Wang Y; Szapary P; Krueger JG
    J Allergy Clin Immunol; 2014 Apr; 133(4):1032-40. PubMed ID: 24679469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of IL-17 Producing Memory Regulatory and Effector T Cells Expressing CD26 Molecule in Patients with Psoriasis.
    Esmaeili B; Mansouri P; Meysamie A; Izad M
    Iran J Allergy Asthma Immunol; 2018 Oct; 17(5):453-463. PubMed ID: 30518187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 Responses Are the Dominant Inflammatory Signal Linking Inverse, Erythrodermic, and Chronic Plaque Psoriasis.
    Xing X; Liang Y; Sarkar MK; Wolterink L; Swindell WR; Voorhees JJ; Harms PW; Kahlenberg JM; Johnston A; Gudjonsson JE
    J Invest Dermatol; 2016 Dec; 136(12):2498-2501. PubMed ID: 27448749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.